Intra-arterial infusion chemotherapy with angiotensin-II for locally advanced and nonresectable pancreatic adenocarcinoma: Further evaluation and prognostic implications

Annals of Surgical Oncology

Volumn 10, Issue 8, 2003, Pages 927-934

  Ohigashi, Hiroaki ^a   Ishikawa, Osamu ^a   Yokayama, Shigekazu ^a   Sasaki, Yo ^a   Yamada, Terumasa ^a   Imaoka, Shingi ^a   Nakaizumi, Akihiko ^a   Uehara, Hiroyuki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Angiotensin II; Coexisting pancreatitis; Hemodynamic change; Intra arterial infusion chemotherapy; Locally advanced pancreatic cancer

Indexed keywords

ANGIOTENSIN; METHOTREXATE; ANGIOTENSIN II; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTERY CATHETER; ARTICLE; BLOOD FLOW; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FIBROSIS; HUMAN; MALE; OUTPATIENT; PANCREAS ADENOCARCINOMA; PANCREATITIS; PROGNOSIS; TREATMENT OUTCOME; ADENOCARCINOMA; CHI SQUARE DISTRIBUTION; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; NONPARAMETRIC TEST; PANCREAS TUMOR; PATHOLOGY; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; ANGIOTENSIN II; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METHOTREXATE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; VASOCONSTRICTOR AGENTS;

EID: 1542544500     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.10.021     Document Type: Article

References (30)

1. Arbuck S. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 1990;7:209-22.
2. Rothman H, Cantrell JE Jr, Lokich J, et al. Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study. Cancer 1991;68:264-8.
3. Rougier P, Zarba JJ, Ducreux M, et al. Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma. Ann Oncol 1993;4:333-6.
4. Hansen R, Quebbeman E, Ritch P, Chitambar C, Anderson T. Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study. Am J Med Sci 1988;295:91-3.
5. Oster MW, Gray R, Panasci L, Perry MC. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM). Cancer 1986;57:29-33.
6. Ryan DP, Kulke MH, Fuchs CS, et al. A phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer 2002;94:97-103.
7. Nguyen TD, Theobald S, Rougier P, et al. Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study. Radiother Oncol 1997;45:129-32.
8. Ardalan B, Ucar A, Reddy R, et al. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas. Cancer 1994;74:1869-73.
9. Thomas CR Jr, Weiden PL, Traverso LW, Thompson T. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703). Am J Clin Oncol 1997;20: 161-5.
10. Crane CH, Abbruzzese JL, Evans DB, et al. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 2002;52:1293-302.
11. Colucci G, Giuliani F, Gebbia V, et al. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale. Cancer 2002;94:902-10.
12. Gazet JC, Smith R. Intra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas. Proc R Soc Med 1974;67: 1182-3.
13. Hafstroem L, Ihse I, Joensson P, Lunderquist A, Stridbeck H. Intraarterial 5-FU infusion with or without oral testolactone treatment in irresectable pancreatic cancer. Acta Chir Scand 1980;146: 445-8.
14. McCracken JD, Olson M, Cruz AB, Leichman L, Oishi N. Radiation therapy combined with intra-arterial 5-FU chemotherapy for treatment of localized adenocarcinoma of the pancreas. Cancer Treat Rep 1982;66:549-51.
15. Smith L, Gazet J. Intra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas. Ann R Coll Surg Engl 1980;62:208-12.
16. Theodors A, Bukowski R, Hewlett J, Livinfston R, Weick J. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Am J Clin Oncol 1982;5:555-8.
17. Ishida H, Makino T, Kobayashi M, Tsuneoka K. Laparoscopic measurement of pancreatic blood flow. Endoscopy 1983;15:107-10.
18. Ohigashi H, Ishikawa O, Nakamori S, et al. Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy for patients with locally advanced pancreatic cancer. Jpn J Cancer Chemother 1993;20:1672-5.
19. Aukland K, Bower BF, Berliner RW. Measurement of local blood flow with hydrogen gas. Circ Res 1964;14:164-87.
20. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
21. 20a. Sobin LH, Wittekind Ch. International Union Against Cancer (UICC), TNM Classification of Malignant Tumors, 6th ed. New York: Wily-Liss, 2002.
22. Zimmerman SE, Smith FP, Schein PS. Chemotherapy of pancreatic carcinoma. Cancer 1981;47:1724-8.
23. Burris HA III, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13.
24. Ohigashi H, Ishikawa O, Sasaki Y, Imaoka S, Iwanaga T. Pancreas cancer: arterial infusion chemotherapy for advanced pancreatic cancer. In: Taguchi T, ed. Arterial Infusion Chemotherapy: Revised and Updated Edition. Tokyo: Japanese Journal of Cancer and Chemotherapy Publications Inc, 1994:416-26.
25. Noguchi S, Miyauchi K, Nishizawa Y, et al. Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma. Cancer 1988;62:467-73.
26. Sasaki Y, Imaoka S, Hasegawa Y, et al. Changes in distribution of blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 1985;55:311-6.
27. Hemingway D, Angerson WJ, Anderson JH, Goldberg JA, McArdle CS, Cooke TG. Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II. Br J Cancer 1992;66:958-60.
28. Sasaki Y, Imaoka S, Hasegawa Y, et al. Distribution of arterial blood flow in human hepatic cancer during chemotherapy: examination by short-lived 81mKr. Surgery 1985;97:409-14.
29. Homma H, Doi T, Mezawa S, et al. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer 2000;89:303-13.
30. Urbach DR, Swanstrom LL, Hansen PD. The effect of laparoscopy on survival in pancreatic cancer. Arch Surg 2002;137:191-9.